Trials / Completed
CompletedNCT03393494
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare Perrigo's Adapalene/BP Gel to Galderma's Epiduo (Adapalene/BP) Gel, and Both Treatments to a Vehicle Control in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 825 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 12 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adapalene and Benzoyl Peroxide Topical Gel | Test product |
| DRUG | Epiduo Topical Product | RLD product |
| DRUG | Placebo | Placebo gel |
Timeline
- Start date
- 2017-12-13
- Primary completion
- 2018-09-30
- Completion
- 2019-01-05
- First posted
- 2018-01-08
- Last updated
- 2021-11-08
- Results posted
- 2021-01-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03393494. Inclusion in this directory is not an endorsement.